FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000130043> ?p ?o ?g. }

• W2000130043 endingPage "1304" @default.
• W2000130043 startingPage "1298" @default.
• W2000130043 abstract "Surgery for hip fracture carries a high risk of venous thromboembolism, despite the use of current thromboprophylactic treatments. Fondaparinux, a synthetic pentasaccharide, is a new antithrombotic agent that may reduce this risk.In a double-blind study, were randomly assigned 1711 consecutive patients undergoing surgery for fracture of the upper third of the femur to receive subcutaneous doses of either 2.5 mg of fondaparinux once daily, initiated postoperatively, or 40 mg of enoxaparin once daily, initiated preoperatively, for at least five days. The primary efficacy outcome was venous thromboembolism up to postoperative day 11. Venous thromboembolism was defined as deep-vein thrombosis detected by mandatory bilateral venography, documented symptomatic deep-vein thrombosis, or documented symptomatic pulmonary embolism. The main safety outcomes were major bleeding and mortality from all causes. The duration of follow-up was six weeks.The incidence of venous thromboembolism by day 11 was 8.3 percent (52 of 626 patients) in the fondaparinux group and 19.1 percent (119 of 624 patients) in the enoxaparin group (P<0.001). The reduction in risk with fondaparinux was 56.4 percent (95 percent confidence interval, 39.0 to 70.3 percent). There were no significant differences between the two groups in the incidence of death or clinically relevant bleeding.In patients undergoing surgery for hip fracture, fondaparinux was more effective than enoxaparin in preventing venous thromboembolism and equally safe." @default.
• W2000130043 created "2016-06-24" @default.
• W2000130043 creator A5009969822 @default.
• W2000130043 creator A5022358325 @default.
• W2000130043 creator A5025045955 @default.
• W2000130043 creator A5035283533 @default.
• W2000130043 date "2001-11-01" @default.
• W2000130043 modified "2023-10-17" @default.
• W2000130043 title "Fondaparinux Compared with Enoxaparin for the Prevention of Venous Thromboembolism after Hip-Fracture Surgery" @default.
• W2000130043 cites W13334420 @default.
• W2000130043 cites W1547774384 @default.
• W2000130043 cites W1583550896 @default.
• W2000130043 cites W1758221915 @default.
• W2000130043 cites W1987745038 @default.
• W2000130043 cites W1997319204 @default.
• W2000130043 cites W2010599049 @default.
• W2000130043 cites W2048032060 @default.
• W2000130043 cites W2058368047 @default.
• W2000130043 cites W2059070394 @default.
• W2000130043 cites W2070822165 @default.
• W2000130043 cites W2070823030 @default.
• W2000130043 cites W2071155706 @default.
• W2000130043 cites W2077207459 @default.
• W2000130043 cites W2118803000 @default.
• W2000130043 cites W2133048039 @default.
• W2000130043 cites W2140446341 @default.
• W2000130043 cites W2152347570 @default.
• W2000130043 cites W2158381418 @default.
• W2000130043 cites W2258503797 @default.
• W2000130043 cites W2265532282 @default.
• W2000130043 cites W2284493660 @default.
• W2000130043 cites W2321004276 @default.
• W2000130043 cites W2325632732 @default.
• W2000130043 cites W2343792664 @default.
• W2000130043 cites W4233876362 @default.
• W2000130043 cites W4236919562 @default.
• W2000130043 cites W4249374822 @default.
• W2000130043 cites W4249798949 @default.
• W2000130043 cites W72021409 @default.
• W2000130043 doi "https://doi.org/10.1056/nejmoa011100" @default.
• W2000130043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11794148" @default.
• W2000130043 hasPublicationYear "2001" @default.
• W2000130043 type Work @default.
• W2000130043 sameAs 2000130043 @default.
• W2000130043 citedByCount "580" @default.
• W2000130043 countsByYear W20001300432012 @default.
• W2000130043 countsByYear W20001300432013 @default.
• W2000130043 countsByYear W20001300432014 @default.
• W2000130043 countsByYear W20001300432015 @default.
• W2000130043 countsByYear W20001300432016 @default.
• W2000130043 countsByYear W20001300432017 @default.
• W2000130043 countsByYear W20001300432018 @default.
• W2000130043 countsByYear W20001300432019 @default.
• W2000130043 countsByYear W20001300432020 @default.
• W2000130043 countsByYear W20001300432021 @default.
• W2000130043 countsByYear W20001300432022 @default.
• W2000130043 countsByYear W20001300432023 @default.
• W2000130043 crossrefType "journal-article" @default.
• W2000130043 hasAuthorship W2000130043A5009969822 @default.
• W2000130043 hasAuthorship W2000130043A5022358325 @default.
• W2000130043 hasAuthorship W2000130043A5025045955 @default.
• W2000130043 hasAuthorship W2000130043A5035283533 @default.
• W2000130043 hasBestOaLocation W20001300431 @default.
• W2000130043 hasConcept C120665830 @default.
• W2000130043 hasConcept C121332964 @default.
• W2000130043 hasConcept C126322002 @default.
• W2000130043 hasConcept C141071460 @default.
• W2000130043 hasConcept C2776265017 @default.
• W2000130043 hasConcept C2776541429 @default.
• W2000130043 hasConcept C2776877702 @default.
• W2000130043 hasConcept C2778269268 @default.
• W2000130043 hasConcept C2778885795 @default.
• W2000130043 hasConcept C2778959117 @default.
• W2000130043 hasConcept C2780011451 @default.
• W2000130043 hasConcept C2780868729 @default.
• W2000130043 hasConcept C2991741193 @default.
• W2000130043 hasConcept C42219234 @default.
• W2000130043 hasConcept C61511704 @default.
• W2000130043 hasConcept C71924100 @default.
• W2000130043 hasConceptScore W2000130043C120665830 @default.
• W2000130043 hasConceptScore W2000130043C121332964 @default.
• W2000130043 hasConceptScore W2000130043C126322002 @default.
• W2000130043 hasConceptScore W2000130043C141071460 @default.
• W2000130043 hasConceptScore W2000130043C2776265017 @default.
• W2000130043 hasConceptScore W2000130043C2776541429 @default.
• W2000130043 hasConceptScore W2000130043C2776877702 @default.
• W2000130043 hasConceptScore W2000130043C2778269268 @default.
• W2000130043 hasConceptScore W2000130043C2778885795 @default.
• W2000130043 hasConceptScore W2000130043C2778959117 @default.
• W2000130043 hasConceptScore W2000130043C2780011451 @default.
• W2000130043 hasConceptScore W2000130043C2780868729 @default.
• W2000130043 hasConceptScore W2000130043C2991741193 @default.
• W2000130043 hasConceptScore W2000130043C42219234 @default.
• W2000130043 hasConceptScore W2000130043C61511704 @default.
• W2000130043 hasConceptScore W2000130043C71924100 @default.
• W2000130043 hasIssue "18" @default.
• W2000130043 hasLocation W20001300431 @default.
• W2000130043 hasLocation W20001300432 @default.

• next